Phesgo combination subcutaneous injection IN (Pertuzumab・Trastuzumab・Borhyaluronidase alpha), from Chugai Pharmaceutical (YJ code: 4291501A2024, standard: 15mL x 1 bottle), is used for HER2-positive breast cancer. It combines pertuzumab and trastuzumab, delivered subcutaneously with hyaluronidase for enhanced absorption.
Phesgo combination subcutaneous injection IN
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).